Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood clots
MedTech
Inari snatches up limb-saving implant maker LimFlow for $415M
The deal comes just weeks after LimFlow netted FDA approval for its approach to re-establish blood flow in the legs of people facing amputation.
Conor Hale
Nov 2, 2023 12:42pm
Bear research reveals potential drug target for blood clots
Apr 18, 2023 9:00am
Omeros saddles up for 2nd charge at transplant drug approval
Mar 14, 2023 9:30am
Hemab uses $135M series B to target neglected blood disorders
Feb 21, 2023 4:07am
Omeros' Hail Mary throw for blood clot med delayed at FDA
Aug 17, 2022 11:21am
How vitamin K findings could have broad implications
Aug 9, 2022 5:45am